Abstract
Introduction
Retail pharmacies provide regular prescription drugs and some specialty prescription drugs, whereas specialty pharmacies focus on distributing specialty prescription drugs, including tumor necrosis factor (TNF) antagonists. It is unknown whether pharmacy type impacts patients’ adherence to anti-TNF therapy. The relationship between pharmacy type (specialty vs. retail) and refill adherence to therapy with the TNF antagonist adalimumab was examined.
Methods
This was a retrospective analysis of dispensing records of patients in the United States who were prescribed a TNF antagonist (adalimumab 40 mg per 0.8-mL injection) during a dispensation period from January 2003 to August 2009. Patients treated with adalimumab were included in the analysis regardless of diagnosis. For each patient, medication refill adherence (MRA) was calculated as total days of supply divided by total number of days evaluated, multiplied by 100. A regression analysis was conducted in which the dependent variable was MRA and the independent variables included pharmacy type (specialty vs. retail pharmacy), reimbursement/payment type, copayment/payment amount per prescription, age, sex, ethnicity, and annual income.
Results
Of the 86,079 patients included, 70% obtained the medication from a specialty pharmacy, 92% were members of Blue Cross and Blue Shield plans, 67% were women, and 81% were white. The average MRA was 84, and the average age was 52 years. Significant predictors (P<0.05) of MRA included pharmacy type, reimbursement/payment type, copayment/payment amount per prescription, age, sex, and ethnicity; and pharmacy type was the strongest predictor. When other independent variables were controlled for, MRA was 16% less for patients who used a retail pharmacy vs. patients who used a specialty pharmacy.
Conclusion
Patients who used a specialty pharmacy to fulfill prescriptions for a TNF antagonist had a greater refill adherence than did patients who used a retail pharmacy.
Article PDF
Similar content being viewed by others
Avoid common mistakes on your manuscript.
References
Mott DA, Doucette WR, Gaither CA, Kreling DH, Pedersen CA, Schommer JC. Pharmacist participation in the workforce: 1990, 2000, and 2004. J Am Pharm Assoc. 2006;46:322–330.
Suchanek D. The rise and role of specialty pharmacy. Biotechnol Healthcare. 2005:31–35.
Fontanez C, McDermott R, Whitehead D. 2004 Specialty Pharmacy Management Guide & Trend Report. St. Louis, MO: CuraScript Pharmacy, 2005. Available at: http://www.curascript.com/bin_web/documents/SRxTrendReport04.pdf. Last accessed March 22, 2010.
Knowledge Source Inc. Specialty Pharmacies Market Overview 2006. Trumbull, CT: Knowledge Source Inc; 2006.
Kaiser Family Foundation. Prescription Drug Trends. Melo Park, CA: Kaiser Family Foundation, 2008. Available at: http://www.kff.org/rxdrugs/upload/3057_07.pdf. Last accessed March 22, 2010.
Aon Consulting. Spring 2009 Health Care Trend Survey. Chicago, IL: Aon, 2009. Available at: http://www.aon.com/attachments/Spring_2009_Healthcare.pdf. Last accessed March 22, 2010.
Adams KT. Specialty pharmacy at a crossroad. Biotechnol Healthcare. 2005:22–30.
Stern D, Reissman D. Specialty pharmacy cost management strategies of private health care payers. J Manag Care Pharm. 2006;12:736–744.
Nash PT, Florin TH. Tumour necrosis factor inhibitors. Med J Aust. 2005;183:205–208.
Kane SV, Chao J, Mulani PM. Adherence to infliximab maintenance therapy and health care utilization and costs by Crohn’s disease patients. Adv Ther. 2009;26:936–946.
Cramer JA, Roy A, Burrell A, et al. Medication compliance and persistence: terminology and definitions. Value Health. 2008;11:44–47.
Cramer JA. Partial medication compliance: the enigma in poor medical outcomes. Am J Manag Care. 1995;1:167–174.
DiMatteo MR, Giordani PJ, Lepper HS, Croghan TW. Patient adherence and medical treatment outcomes: a meta-analysis. Med Care. 2002;40:794–811.
Vermeire E, Hearnshaw H, Van Royen P, Denekens J. Patient adherence to treatment: three decades of research. A comprehensive review. J Clin Pharm Ther. 2001;26:331–342.
Vik SA, Maxwell CJ, Hogan DB. Measurement, correlates, and health outcomes of medication adherence among seniors. Ann Pharmacother. 2004;38:303–312.
Leventhal H, Cameron L. Behavioral theories and the problem of compliance. Patient Educ Couns. 1987;10:117–138.
Chao J. Improving medication adherence: the role of the health care delivery system and health care providers. J Manag Care Pharm. 2007;13:807–809.
Lee JK, Grace KA, Taylor AJ. Effect of a pharmacy care program on medication adherence and persistence, blood pressure, and low density lipoprotein cholesterol: a randomized controlled trial. JAMA. 2006;296:2563–2571.
Stockl KM, Shin JS, Gong S, Harada AS, Solow BK, Lew HC. Improving patient self-management of multiple sclerosis through a disease therapy management program. Am J Manag Care. 2010;16:139–144.
Cohen SM, Kwasny MJ, Ahn J. Use of specialty care versus standard retail pharmacies for treatment of hepatitis C. Ann Pharmacother. 2009;43:202–209.
Express Scripts Inc. Factors predicting patient compliance with specialty drug therapy for multiple sclerosis, inflammatory conditions and hepatitis C. St. Louis, MO: Express Scripts Inc., 2006. Available at: http://www.express-scripts.com/research/studies/pharmacybenefitresearch/specialtypharmacyservices/docs/factorsPredictingPatientCompliance.pdf. Last accessed May 3, 2010.
[no authors] Humira prescribing information. North Chicago, IL: Abbott Laboratories, 2009.
FDA. National Drug Code Directory. Available at: http://www.accessdata.fda.gov/scripts/cder/ndc/default.cfm. Last accessed July 1, 2010.
Hess LM, Raebel MA, Conner DA, Malone DC. Measurement of adherence in pharmacy administrative databases: a proposal for standard definitions and preferred measures. Ann Pharmacother. 2006;40:1280–1288.
Kleinbaum DG, Kupper LL, Muller KE, Nizam A. Regression diagnostics. In: Applied Regression Analysis and Other Multivariable Methods. 3rd edition. Belmont, CA: Duxbury Press, 1998:237–249.
Schectman JM, Bovbjerg VE, Voss JD. Predictors of medication-refill adherence in an indigent rural population. Med Care. 2002;40:1294–1300.
Serono. Serono Injectables Digest. 2nd edition. Rockland, MA: Serono; 2006.
Kotler P, Keller KL. Designing and managing integrated marketing channels. In: Marketing Management. 13th edition. Upper Saddle River, NJ: Prentice Hall, 2008:409–440.
Author information
Authors and Affiliations
Corresponding author
Additional information
This article is published with open access at Springerlink.com
Rights and permissions
This article is published under an open access license. Please check the 'Copyright Information' section either on this page or in the PDF for details of this license and what re-use is permitted. If your intended use exceeds what is permitted by the license or if you are unable to locate the licence and re-use information, please contact the Rights and Permissions team.
About this article
Cite this article
Liu, Y., Yang, M., Chao, J. et al. Greater refill adherence to adalimumab therapy for patients using specialty versus retail pharmacies. Adv Therapy 27, 523–532 (2010). https://doi.org/10.1007/s12325-010-0050-5
Received:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12325-010-0050-5